Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2803)
All Articles published online
|
Mar 15, 2004 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang J, Wang WL, Li Q, Qiao Q. Expression of transforming growth factor-α and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol 2004; 10(6): 830-833 [PMID: 15040026 DOI: 10.3748/wjg.v10.i6.830] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i6/830.htm |
| Number | Citing Articles |
| 1 |
X.H. Liu, M.H. Pan, Z.F. Lu, B. Wu, Q. Rao, Z.Y. Zhou, X.J. Zhou. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Digestive and Liver Disease 2008; 40(7): 560 doi: 10.1016/j.dld.2007.12.011
|
| 2 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
|
| 3 |
K Breuhahn, T Longerich, P Schirmacher. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006; 25(27): 3787 doi: 10.1038/sj.onc.1209556
|
| 4 |
P-C Chang, C-W Chi, G-Y Chau, F-Y Li, Y-H Tsai, J-C Wu, Y-H Wu Lee. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006; 25(14): 1991 doi: 10.1038/sj.onc.1209239
|
| 5 |
Masafumi Shimoda, Jack R. Wands. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 160 doi: 10.1016/B978-0-323-34062-5.00123-0
|
| 6 |
Krizia Pocino, Annunziata Stefanile, Valerio Basile, Cecilia Napodano, Francesca D’Ambrosio, Riccardo Di Santo, Cinzia Anna Maria Callà, Francesca Gulli, Raffaele Saporito, Gabriele Ciasca, Francesco Equitani, Umberto Basile, Mariapaola Marino. Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace. Journal of Personalized Medicine 2022; 13(1): 5 doi: 10.3390/jpm13010005
|
| 7 |
Karin Komposch, Maria Sibilia. EGFR Signaling in Liver Diseases. International Journal of Molecular Sciences 2015; 17(1): 30 doi: 10.3390/ijms17010030
|
| 8 |
Jen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, Lea-Yea Chuang, Zu-Yau Lin, Min-Yuh Hsieh, Shinn-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Min-Lung Yu, Chia-Yen Dai, Jung-Fa Tsai. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma. Tumor Biology 2014; 35(4): 3689 doi: 10.1007/s13277-013-1488-2
|
| 9 |
Ali Alqahtani, Zubair Khan, Abdurahman Alloghbi, Tamer S. Said Ahmed, Mushtaq Ashraf, Danae M. Hammouda. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina 2019; 55(9): 526 doi: 10.3390/medicina55090526
|
| 10 |
Teresa Garcia-Lezana, Juan Luis Lopez-Canovas, Augusto Villanueva. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 63 doi: 10.1016/bs.acr.2020.10.002
|
| 11 |
Woo Sung Moon, Ho Sung Park, Ki Hoon Yu, Min Young Park, Kyung Ryoul Kim, Kyu Yun Jang, Jong Suk Kim, Baik Hwan Cho. Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. Human Pathology 2006; 37(10): 1324 doi: 10.1016/j.humpath.2006.04.022
|
| 12 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 13 |
Matthew Hennig, Michele T. Yip-Schneider, Patrick Klein, Sabrina Wentz, Jesus M. Matos, Courtney Doyle, Jennifer Choi, Huangbing Wu, Amanda O'Mara, Alex Menze, Stephen Noble, Iain H. McKillop, C. Max Schmidt. Ethanol-TGFα-MEK Signaling Promotes Growth of Human Hepatocellular Carcinoma. Journal of Surgical Research 2009; 154(2): 187 doi: 10.1016/j.jss.2008.11.836
|
| 14 |
Y. J. Kim, H. Y. Kim, J. S. Kim, J. -H. Lee, J. -H. Yoon, C. Y. Kim, B. L. Park, H. S. Cheong, J. S. Bae, S. Kim, H. D. Shin, H. -S. Lee. Putative association of transforming growth factor-α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis 2009; doi: 10.1111/j.1365-2893.2009.01205.x
|
| 15 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_173-1
|
| 16 |
Matthew Hennig, Michele T. Yip‐Schneider, Sabrina Wentz, Huangbing Wu, S. K. Hekmatyar, Patrick Klein, Navin Bansal, C. Max Schmidt. Targeting mitogen‐activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems†. Hepatology 2010; 51(4): 1218 doi: 10.1002/hep.23470
|
| 17 |
Masafumi Shimoda, Jack R. Wands. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 142 doi: 10.1016/B978-1-4377-1454-8.00109-0
|
| 18 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3159 doi: 10.1007/978-3-319-26956-6_173
|
| 19 |
Randa A. Zaghloul, Nehal M. Elsherbiny, Hany I. Kenawy, Amr El-Karef, Laila A. Eissa, Mamdouh M. El-Shishtawy. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. Life Sciences 2017; 185: 114 doi: 10.1016/j.lfs.2017.07.026
|
| 20 |
Vera Lucia Pannain, José Rodrigo Morais, Osmar Damasceno-Ribeiro, Venâncio Avancini-Alves. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue. Annals of Hepatology 2012; 11(4): 495 doi: 10.1016/S1665-2681(19)31463-2
|
| 21 |
Afkar Abdel‐Ghany Badawy, Ali El‐Hindawi, Olfat Hammam, Mona Moussa, Samia Gabal, Noha Said. Impact of epidermal growth factor receptor and transforming growth factor–α on hepatitis C virus‐induced hepatocarcinogenesis. APMIS 2015; 123(10): 823 doi: 10.1111/apm.12431
|